Brief: Aft Pharmaceuticals HY Rev Rises 14% To NZ$55.5 Million
18/11/2021 01:35
Nov 18 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* HY REVENUE RISES 14% TO NZ$55.5 MILLION
* GUIDANCE FOR FY22 OPERATING PROFIT REAFFIRMED
* HY PROFIT AFTER TAX ATTRIBUTABLE NZ$4.2 MILLION VERSUS
NZ$1.2
MILLION
Further company coverage: AFT.NZ
((reuters.briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV